We provide you with 20 years of free, institutional-grade data for GLUE stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of GLUE. Explore the full financial landscape of GLUE stock.
Total insider purchase within 3 month on this page: $0
Total insider selling within 3 month on this page: -$2,423,618
| Name | Action | Shares | Avg Price | Amount | Reported Date |
|---|---|---|---|---|---|
| Townson Sharon | Sale | -6,000 | $23.25 | $139,497 | 2026-07-07 |
| Townson Sharon | Derivatives Exercise | 6,000 | 2026-07-07 | ||
| Janku Filip | Sale | -5,407 | $24.5 | $132,472 | 2026-07-01 |
| Janku Filip | Derivatives Exercise | 5,407 | 2026-07-01 | ||
| Janku Filip | Sale | -6,000 | $22.95 | $137,700 | 2026-06-30 |
| Janku Filip | Derivatives Exercise | 6,000 | 2026-06-30 | ||
| Manning Anthony M. | Sale | -10,000 | $23.11 | $231,100 | 2026-06-30 |
| Manning Anthony M. | Derivatives Exercise | 10,000 | 2026-06-30 | ||
| Champoux Jennifer | Sale | -2,175 | $20 | $43,500 | 2026-06-25 |
| Champoux Jennifer | Derivatives Exercise | 2,175 | 2026-06-25 | ||
| Townson Sharon | Sale | -3,000 | $20 | $60,000 | 2026-06-25 |
| Townson Sharon | Derivatives Exercise | 3,000 | 2026-06-25 | ||
| Janku Filip | Sale | -41,845 | $20.22 | $846,164 | 2026-06-25 |
| Janku Filip | Derivatives Exercise | 36,000 | 2026-06-25 | ||
| Townson Sharon | Sale | -3,000 | $19 | $57,000 | 2026-06-18 |
| Townson Sharon | Derivatives Exercise | 3,000 | 2026-06-18 | ||
| Champoux Jennifer | Sale | -2,176 | $19 | $41,344 | 2026-06-18 |
| Champoux Jennifer | Derivatives Exercise | 2,176 | 2026-06-18 | ||
| Warmuth Markus | Sale | -5,466 | $19.41 | $106,106 | 2026-06-02 |
| Townson Sharon | Sale | -6,000 | $19.87 | $119,220 | 2026-06-01 |
| Townson Sharon | Derivatives Exercise | 6,000 | 2026-06-01 | ||
| Champoux Jennifer | Sale | -2,175 | $20 | $43,500 | 2026-05-28 |
| Champoux Jennifer | Derivatives Exercise | 2,175 | 2026-05-28 | ||
| Champoux Jennifer | Sale | -2,176 | $19 | $41,344 | 2026-05-26 |
| Champoux Jennifer | Derivatives Exercise | 2,176 | 2026-05-26 | ||
| Manning Anthony M. | Sale | -10,000 | $18.01 | $180,100 | 2026-05-22 |
| Manning Anthony M. | Derivatives Exercise | 10,000 | 2026-05-22 | ||
| Warmuth Markus | Sale | -5,467 | $18.92 | $103,447 | 2026-05-05 |
| Warmuth Markus | Sale | -8,000 | $17.64 | $141,125 | 2026-04-15 |
| Nickson Philip | Sale | -5,845 | $17.69 | $103,413 | 2026-04-10 |
| Bowen Matthew | Grant, award...etc | 4,300 | 2026-04-07 | ||
| Bowen Matthew | Initial | 2026-04-07 | |||
| Dunn Edmund | Sale | -139 | $17.96 | $2,496 | 2026-03-05 |
| Warmuth Markus | Sale | -5,466 | $17.92 | $97,974 | 2026-03-04 |
| Dunn Edmund | Sale | -25,700 | $18.1 | $465,209 | 2026-03-02 |
| Dunn Edmund | Derivatives Exercise | 25,700 | 2026-03-02 | ||
| Janku Filip | Sale | -9,189 | $19.5 | $179,161 | 2026-02-24 |
| Warmuth Markus | Sale | -5,466 | $23.24 | $127,042 | 2026-01-09 |
| Dunn Edmund | Sale | -2,062 | $4.45 | $9,174 | 2025-06-04 |
| Leo Chandra P. | Open Market Purchase | 10,000 | $5.84 | 2025-03-25 | |
| Nickson Philip | Grant, award...etc | 36,000 | 2025-01-06 | ||
| Dunn Edmund | Grant, award...etc | 11,850 | 2025-01-06 | ||
| Janku Filip | Grant, award...etc | 36,000 | 2025-01-06 | ||
| Champoux Jennifer | Grant, award...etc | 30,000 | 2025-01-06 | ||
| Warmuth Markus | Grant, award...etc | 128,000 | 2025-01-06 | ||
| Townson Sharon | Grant, award...etc | 36,000 | 2025-01-06 | ||
| Versant Venture Capital VI, L.P. | Sale | -157,895 | $9.66 | $1,525,155 | 2024-10-30 |
| Versant Venture Capital VI, L.P. | Sale | -1,132,566 | $6.53 | $7,395,203 | 2024-09-24 |
| Versant Venture Capital VI, L.P. | Sale | -567,213 | $6 | $3,403,278 | 2024-09-13 |
| Dunn Edmund | Sale | -1,610 | $3.83 | $6,166 | 2024-07-09 |
| Dunn Edmund | Sale | -1,207 | $4.04 | $4,876 | 2024-06-05 |
| Dunn Edmund | Initial | 2023-08-18 |
The information provided in this report about GLUE stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Monte Rosa Therapeutics Inc(NASDAQ:GLUE) 
Share this website to your friends